Clinical Trial Update: A Clinical Investigation of the M2a- Taper™ Hip System

View source ↗

Summary

Biomet Orthopedics' clinical trial of the M2a-Taper Hip System has been terminated; the study involved degenerative joint disease conditions such as osteoarthri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avascular Necrosis
• Osteoarthritis

Drugs mentioned

• M2a-Taper Hip System

Snippet

Sponsor: Biomet Orthopedics, LLC | Conditions: Non-inflammatory Degenerative Joint Disease, Osteoarthritis | Status: TERMINATED